Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Rajiv Suri of RNA, Technology and IP Attorneys consider a Supreme Court ruling where income from a software sale by non-resident companies to resident is not a ‘royalty’ payment -
Sponsored by Daniel LawCarolina Schueler of Daniel Law discusses why naming rights and sponsorship deals could be a profitable two-way partnership that may last for decades
-
Sponsored by IncoproSimon Baggs, CEO of Incopro, discusses the success of the group’s technology-led strategy and considers the key dynamics of the evolving brand protection world
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law describes how patent challenges have become even more important under the revised drug pricing framework in South Korea
-
Sponsored by AFD China Intellectual Property Law OfficeJie He, Jingjing Wu and Xia Zheng of AFD China Intellectual Property Law Office discuss trademark registrations and the obstacles to overcome to establish a successful trademark environment
-
Sponsored by Bridgeon Law FirmAt a time when the China Congress has enacted new laws to strengthen patent protection, Wei Shi and Youping Ma of Bridgeon Law Firm provide advice on preparing for a jurisdiction objection request
